Imaging Studies II: Ultrasonography
Ultrasonography
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 11, 2026

Contrast Imaging in Mouse Embryos Using High-frequency Ultrasound
Published on: March 4, 2015
James Shue-Min Yeh1, Charles A Sennoga2, Ellen McConnell3
1National Heart and Lung Institute, Imperial College London, London, UK; Department of Cardiology, Hammersmith Hospital, London, UK; Imaging Sciences Department, Medical Research Council, Imperial College London, London, UK.
This study introduces a new method to precisely measure specific protein levels in the body using ultrasound. By tracking how targeted microbubbles disappear from the heart, researchers can accurately estimate the amount of E-selectin present, offering a more sensitive diagnostic tool than previous techniques.
Area of Science:
Background:
Current diagnostic imaging often relies on subjective assessments that lack precise numerical data for clinical decision-making. Ultrasound molecular imaging using targeted microbubbles remains largely semi-quantitative, which restricts its overall diagnostic utility. This limitation prevents clinicians from accurately mapping protein expression levels within specific tissues. No prior work had resolved the challenge of achieving reliable acoustic quantification of molecular targets. That uncertainty drove the development of new analytical frameworks for signal processing. Prior research has shown that microbubbles can effectively bind to specific markers in the vasculature. However, existing methods struggle to differentiate between bound and circulating contrast agents accurately. This gap motivated the creation of a more robust mathematical approach for signal interpretation.
Purpose Of The Study:
The researchers aimed to develop a novel method for the acoustic quantification of molecular expression in cardiac tissue. Existing techniques often rely on semi-quantitative assessments, which limit their diagnostic power and clinical utility. This study addresses the need for more precise numerical data in ultrasound molecular imaging. The authors sought to overcome the limitations of traditional methods that fail to differentiate between bound and circulating contrast agents. They hypothesized that analyzing the elimination phase of signal intensity curves would provide a more accurate measurement. By focusing on the kinetics of microbubble disappearance, they intended to isolate the signal from retained bubbles. This effort was motivated by the desire to improve the sensitivity and dynamic range of current diagnostic imaging tools. The investigation explores whether this mathematical approach can reliably estimate protein concentrations in vivo.
Main Methods:
The investigators designed a novel analytical framework to interpret signal decay patterns from contrast-enhanced ultrasound. They induced E-selectin expression in murine cardiac tissue using lipopolysaccharide injections. Imaging occurred with a clinical scanner operating in contrast pulse sequencing mode. The team maintained a mechanical index between 0.22 and 0.26 at a frequency of 14 MHz. They recorded myocardial time-signal intensity curves following the administration of targeted microbubbles. The review approach involved fitting a bi-exponential mathematical model to the elimination phase of these curves. This process isolated the signal intensity of retained versus freely circulating contrast agents. Finally, they compared these acoustic results against protein concentrations measured via reverse transcriptase real-time quantitative polymerase chain reaction.
Main Results:
The maximum signal intensity of retained bubbles showed a strong correlation with E-selectin expression levels, with an absolute r-value exceeding 0.8. This new technique demonstrated a superior dynamic range compared to conventional methods that rely on single-point intensity measurements. The researchers successfully quantified the elimination rate constants for both circulating and retained bubble populations. Their model simultaneously calculated useful parameters such as the microbubble half-life within the cardiac tissue. The study confirmed that both the signal intensity and the duration of post-treatment exposure were linearly related to protein concentration. This approach provided higher sensitivity than the traditional method of measuring signal intensity at 20 minutes post-injection. The data indicate that the bi-exponential curve-fitting accurately distinguishes between bound and unbound contrast agents. These findings establish a robust basis for acoustic quantification of molecular markers in vivo.
Conclusions:
The researchers demonstrate that acoustic quantification of molecular expression is achievable through bubble elimination analysis. This approach provides a superior dynamic range compared to traditional signal intensity measurements. The study confirms that maximum signal intensity of retained bubbles correlates strongly with protein concentration. These findings suggest that the technique improves sensitivity for detecting molecular markers in vivo. The authors propose that this method offers a reliable alternative to conventional acoustic quantification strategies. Furthermore, the model allows for the simultaneous calculation of additional parameters like microbubble half-life. The results indicate that this analytical framework holds potential for enhancing diagnostic precision in clinical settings. Future applications may benefit from the increased sensitivity provided by this bi-exponential modeling technique.
The researchers propose a time-signal intensity curve analytical method based on bubble elimination. By fitting a bi-exponential equation to the myocardial signal decay, they isolate the intensity of retained bubbles, which correlates with E-selectin protein concentration, unlike simpler methods that only measure signal at a single time point.
The authors utilized E-selectin-targeting microbubbles as the primary contrast agent. These particles are designed to bind specifically to the target protein, allowing for the differentiation between freely circulating and tissue-bound populations during the ultrasound scanning process.
A clinical ultrasound scanner operating in contrast pulse sequencing mode at 14 MHz is necessary. This specific frequency and mode are required to maintain a mechanical index between 0.22 and 0.26, ensuring optimal bubble detection while minimizing premature destruction during the imaging sequence.
The researchers employed reverse transcriptase real-time quantitative polymerase chain reaction data as the gold standard. This molecular data type validates the acoustic measurements by confirming the actual concentration of E-selectin protein present in the mouse heart tissue samples.
The study measures the elimination rate constants and maximum signal intensities of microbubbles. These parameters are derived from the bi-exponential curve-fitting process, providing a comprehensive profile of bubble behavior within the myocardium that exceeds the capabilities of standard intensity-based measurements.
The authors claim that this new approach exhibits a greater dynamic range and sensitivity than conventional methods. They suggest that their technique provides a more accurate representation of protein expression levels by accounting for the kinetics of both circulating and retained contrast agents.